Skip to content
Review

Induced pluripotent stem cell–derived macrophages (iMacs) in translational medicine: Disease models, drug testing, and therapeutic applications

Aug 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 137 references
Medicine

TL;DR

iMacs are a versatile bridge between mechanistic immunology and next-generation translational medicine and enable large-scale production, precise genetic modification, and accurately mimic host-pathogen interactions, autoimmune phenotypes, metabolic inflammation, and tissue-specific macrophage functions.

View source

Similar papers

Open access Aug 2026

Highly Efficient Derivation of Functional Human-Induced Pluripotent Stem Cell-Derived Macrophages under Serum-Free Conditions to Study Innate Immune Responses

A robust, reproducible, efficient serum-free and feeder-free protocol for generating functional iMacs and characterizing their innate immune properties, providing a versatile model for investigating innate immunity, host-pathogen interactions, and interferon signaling.

Hani Hosseini Far, Le Ying, L. Gearing et al. · 0 citations
Open access Sep 2026

High-throughput platforms for genetic perturbation screening using CRISPR/Cas9 in human iPSC-derived macrophages for drug discovery

A scalable, semi-automated, and physiologically relevant hiPSC-derived macrophage model, rigorously characterised through deep comparative multi-omics is established and how genetic perturbations alter pro- and anti-inflammatory transcriptional signatures and significantly impact functional phenotypes are showcased.

Matteo Martufi, Eleni Karagianni, Tasos Papanikos et al. · 0 citations
Review Open access Sep 2026

Immunomodulatory Properties of Mesenchymal Stem Cells and Their Extracellular Vesicles: Potential Clinical Applications in Autoimmune Diseases

Mesenchymal stem cells (MSCs)/mesenchymal stromal cells and their extracellular vesicles (EVs), particularly exosomes, have emerged as therapeutic candidates in regenerative medicine due to their multipotency, low immunogenicity, and extensive immunomodulatory properties. This narrative review provides a narrative synt...

E. Ciarrochi, Juan B. Ciarrochi · 0 citations
Review Open access Sep 2026

Engineered mesenchymal stem cell-derived extracellular vesicles as programmable biomaterial platforms for liver fibrosis: design principles, manufacturing and clinical translation

Liver fibrosis remains a major unmet clinical challenge characterized by persistent activation of hepatic stellate cells (HSCs), chronic inflammatory remodeling, and impaired hepatocyte regeneration. Although mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as promising cell-free therapeutics...

Fang-Hong Wang, Ke-Xiang Zhu, Xiao-Liang Zhu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.